Hempalta Corp. (TSXV:HEMP) processes industrial hemp at scale to produce a range of consumer and commercial products using its proprietary processing technology, HempTrain, which converts industrial hemp into high-volume, high-grade products. Hempalta’s products include animal bedding, garden mulch and construction products such as hempcrete – a biocomposite material for construction and insulation made of hemp hurds and lime. Industrial hemp is highly versatile and can be grown in different climates and soil conditions. HEMPALTA owns 50.1 percent of HCS, which uses a science-based quantif ..read more

Pharmacies in Canada are poised to occupy a larger space in the overall healthcare landscape, blurring the previously well-defined responsibilities of primary and secondary healthcare providers. Pharmacists have traditionally played a significant role in Canada’s healthcare market. Patients go to their primary healthcare providers while pharmacists dispense medications, occupying a secondary, supporting role in the medical sector. However, a changing landscape in the healthcare industry is promising to transform pharmacies into larger, more holistic community healthcare providers. The growin ..read more

The Board of BPH Global Ltd (ASX: BP8) (Company) announces that the Company has entered into a legally binding Term Sheet (Term Sheet) with Australian-based company Nutura Organic Ltd (Nutura) for the purchase of adult milk formula to enable the Company to undertake a pilot study in China. Highlights Purchase of adult milk formula to commence pilot study in China Proposed development of adult milk formula products infused with TCM ingredients including sialic acid and nutraceuticals extracted from raw birds’ nest and seaweed Focus on sales and distribution in China Nutura is a Melbourne-b ..read more

Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that its wholly owned Canadian subsidiary, Mernova, continues to make strong operational progress. Highlights: Additional product launches across various provinces in addition to those previously announced Agreement with Best Kind Edibles signed for manufacturing of cannabis edibles as an extension to existing product suite Q2 confirmed purchase orders of $1.3m to date, highlighting ongoing strength of Ritual brand at the midpoint of the quarter Purchase orders follow unaudited Q1 revenues of $1.75m ..read more

Since the legalisation of medical cannabis in 2016, Australia has been steadily developing its marijuana industry — and it’s been attracting attention from international players and investors. With a quickly growing population of over 27 million people and a robust agricultural industry, the country could be positioned to mould itself into a major force in the international cannabis space. Here the Investing News Network takes a look at how the cannabis industry in Australia has been shaping up since legalisation. Read on to see what you need to know about investing in cannabis down under ..read more

Major cannabis industry player Tilray Brands (TSX:TLRY,NASDAQ:TLRY) disappointed investors with its latest quarterly results this week, falling short of analysts’ expectations in the wake of a number of acquisitions. Meanwhile, Nebraska lawmakers have proposed a lower tax rate for CBD after their initial offer was criticized, and unionized cannabis workers are preparing to strike on 4/20 as they seek improved benefits. Stay up to date on the latest news, trends and policy developments in the cannabis industry with our round-up below. Tilray’s latest quarterly results disappoint Tilray relea ..read more

The Associated Press reported Tuesday (April 30) that the US Drug Enforcement Administration (DEA) was on the cusp of rescheduling cannabis from a Schedule I substance, the same category as heroin and methamphetamines, to Schedule III. The Department of Health and Human Services suggested cannabis be reclassified on August 29, 2023, and the DEA has been deliberating on the decision for months, urged by lawmakers to heed the recommendation. According to the report, Attorney General Merrick Garland was scheduled to submit the proposal to the White House Office of Management and Budget on Tues ..read more

Notice is hereby given that an Extraordinary General Meeting of Shareholders of BPH Global Limited ACN 009 104 330 will be held at 3:00pm AEST on 24 May 2024 at Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000 (Meeting). The Explanatory Statement to this Notice of Meeting provides additional information on matters to be considered at the Extraordinary General Meeting. The Explanatory Statement and the Proxy Form forms part of this Notice of Meeting. The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to v ..read more

Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that is has achieved approximately $4.1m of unaudited revenues for Q1 of FY24, marking a 79% increase on Q1 FY23 revenues of $2.3m. The result provides a strong foundation for the remainder of FY24. Highlights: Unaudited Q1 FY24 revenues of $4.1m, a 79% increase on Q1 FY23 Follows strong Melodiol group FY 2023 revenues of $21.6m (an increase of 148% on FY 2022) Revenues were driven by strong performance at Mernova, which recorded $1.7m in revenues for the quarter. During the quarter, Mernova contin ..read more

Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that its wholly owned Australian subsidiary, Health House Australia, continues to make strong operational progress. Highlights: Health House Australia announces the planned launch of its medicinal cannabis clinic in Q2 of 2024 The group is also pleased to announce that it has added several new suppliers during Q1 of 2024 Health House Australia was a key contributor to Melodiol group FY 2023 revenues of $21.6m (an increase of 148% on FY 2022) Health House Australia and Health House UK contributed $11 ..read more